Navigation Links
Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18

ed antibody response to active immunization (see PRECAUTIONS, Drug Interactions). As with other intramuscular injections, GARDASIL should not be given to individuals with bleeding disorders such as hemophilia or thrombocytopenia, or to persons on anticoagulant therapy unless the potential benefits clearly outweigh the risk of administration. If the decision is made to administer GARDASIL to such persons, it should be given with steps to avoid the risk of hematoma following the injection. Information for the Patient, Parent, or Guardian The health care provider should inform the patient, parent, or guardian that vaccination does not substitute for routine cervical cancer screening. Women who receive GARDASIL should continue to undergo cervical cancer screening per standard of care. The health care provider should provide the vaccine information required to be given with each vaccination to the patient, parent, or guardian. The health care provider should inform the patient, parent, or guardian of the benefits and risks associated with vaccination. For risks associated with vaccination, see PRECAUTIONS and ADVERSE REACTIONS. GARDASIL is not recommended for use in pregnant women. The health care provider should inform the patient, parent, or guardian of the importance of completing the immunization series unless contraindicated. Patients, parents, or guardians should be instructed to report any adverse reactions to their health care provider. Drug Interactions Use with Other Vaccines Results from clinical studies indicate that GARDASIL may be administered concomitantly (at a separate injection site) with hepatitis B vaccine (recombinant) (see CLINICAL PHARMACOLOGY, Studies with Other Vaccines). Co-administration of GARDASIL with other vaccines has not been studied. Use with Hormonal Contraceptives In clinical studies, 13,293 subjects (vaccine = 6644; placebo = 6649) who had post-Month 7 foll
'"/>




Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32

Related medicine technology :

1. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
2. New Proof of Genisteins Efficacy and Safety for Osteopenia and Osteoporosis Published in Annals of Internal Medicine
3. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
4. Interim Analysis of Crinone Pregnancy Study to Be Published in American Society for Reproductive Medicine Journal
5. VIVUS Announces Abstract Published at American Diabetes Association Scientific Sessions
6. Anacor Identifies a Novel Mechanism for Its Lead Anti-Fungal Drug, AN2690; Findings Published in Science
7. Research on New Treatment for Neglected Disease Published in The New England Journal of Medicine
8. Landmark Study Published in the New England Journal of Medicine Shows Important Benefits of Eprodisate (KIACTA) Treatment for Patients with Amyloid A (AA) Amyloidosis
9. Newly Published Data from Large Study Support Cardiovascular Safety of Avandia (Rosiglitazone Maleate)
10. Javelin Pharmaceuticals Phase II Rylomine (Intranasal Morphine) Data Published in Pain Medicine
11. Newly Published Data Demonstrates Superiority of Cipralex Over Duloxetine for Acute Treatment of Depression
Post Your Comments:
(Date:9/2/2015)... 2015 Simplified Genetics , the only provider ... and safety in the U.S., announced today the launch of ... improved overall health found within specific genes – all with ... The tests include Simply Fit and ... genetic analysis that maps four key genes to provide individuals ...
(Date:9/2/2015)... 2, 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ... company focused on tissue protection, repair and regeneration, ... and Chief Executive Officer, will present a corporate ... Conference, sponsored by H.C. Wainwright & ... 2015 at the St. Regis Hotel in New ...
(Date:9/2/2015)... SAINT PAUL, Minn. , Sept. 2, 2015 /PRNewswire/ ... company, today scheduled a conference call to discuss its ... ended July 31, 2015. The call will be at ... Company will report financial results for the third quarter ... September 10, 2015. Participants can dial ...
Breaking Medicine Technology:Simplified Genetics Decodes DNA's Blueprint for Individual Health and Safety 2Simplified Genetics Decodes DNA's Blueprint for Individual Health and Safety 3RegeneRx to Present at Rodman & Renshaw Global Investment Conference 2RegeneRx to Present at Rodman & Renshaw Global Investment Conference 3MGC Diagnostics Corporation to Report Third Quarter Fiscal 2015 Financial Results on Thursday, September 10, 2015 2
(Date:9/2/2015)... ... September 02, 2015 , ... A third party administrator (TPA) ... seeing a significant increase in unlawful tactics used by out-of-network (OON) ambulatory surgical ... of OON ASCs encouraging members to have elective procedures done at their facilities ...
(Date:9/2/2015)... ... 2015 , ... Amada Senior Care, premier provider of in-home care and assisted ... County location. Amada franchise partners Mike and Mell Fleming came to the senior ... over 20 years in medical device sales while Mell spent over 30 years as ...
(Date:9/2/2015)... ... September 02, 2015 , ... EDAC Systems, Inc., ... management solutions and services to both government and commercial clients, today announced the ... utility for IBM’s Datacap document capture platform. EDAC PurePAGE processes and enhances ...
(Date:9/2/2015)... ... 2015 , ... “ G-Hold ” was featured on NewsWatch as part of ... consumers. Amanda Forstrom, a technology expert and special reporter for NewsWatch, conducted the review ... a tablet while reducing the likelihood of it dropping. , Tablets like the iPad ...
(Date:9/2/2015)... , ... September 02, 2015 , ... Pentec Health, Inc., ... Inc. 5000 List for an impressive sixth consecutive year. Less than 5 % of ... twelve firms in the “health” sector. Pentec’s 3-year revenue growth rate of 65% ...
Breaking Medicine News(10 mins):Health News:TPA Cracks Down on Forbidden Tactics Used by Out-of-Network Surgical Centers 2Health News:TPA Cracks Down on Forbidden Tactics Used by Out-of-Network Surgical Centers 3Health News:Amada Senior Care Expands to Greater Kansas City 2Health News:EDAC Systems, Inc. announces a new version of its Image Enhancement and Image Re-Sizing utility EDAC’s PurePAGE® 2Health News:EDAC Systems, Inc. announces a new version of its Image Enhancement and Image Re-Sizing utility EDAC’s PurePAGE® 3Health News:Comfortably Hold a Tablet with G-Hold Hands Free Tablet Holder 2Health News:Pentec Health Once Again Named One of the Fastest-Growing Private Companies in America 2
... a Phase 1 clinical trial on a new experimental ... first new class of anti-TB drugs in the past ... and drug-resistant TB. The study is the first ... the National Institutes of Health through the Hinckley-based research ...
... protecting bikers, brains, may also be contributing to hearing ... find out why. The distinctive roar of a ... biggest source of noise for motorcyclists is actually generated ... legal speeds, the sound can exceed safe levels. Now, ...
... have received a major funding boost of 550,000 from ... into the pathological processes underpinning Alzheimer,s disease, the most ... the UK. The funding will be used to ... electrical signalling go wrong in the Alzheimer,s disease brain. ...
... (HealthDay News) -- Low blood pressure while undergoing dialysis ... blood vessels are connected to the dialysis machine, a ... a sudden drop in blood pressure during dialysis can ... and long-term problems such as stroke, seizure, heart damage ...
... research focusing on high-frequency oscillations, termed ripples and ... provide an important marker for the localization of ... to the study now available in Epilepsia ... Epilepsy (ILAE), the resection of brain regions containing ...
... Crawford, PhD, a clinical associate professor of psychiatry and ... at Boston University School of Medicine (BUSM), has been ... Excellence in Diversity Training by the Association of Psychology ... presented to Crawford during the American Psychological Association,s Convention ...
Cached Medicine News:Health News:Scientists receive funding boost to further research into disease mechanisms of Alzheimer’s 2Health News:Blood Pressure Drop During Dialysis May Raise Clot Risk 2Health News:Fast ripples confirmed to be valuable biomarker of area responsible for seizure activity in children 2
... protein 4 (IGFBP-4) is a 24 kDa protein ... IGF-I and IGF-II. It is also present in ... 28 kDa. IGFBP-4 has been identified in all ... types, including fibroblasts, neuroblastoma, prostate and bone cells ...
... the adrenal gland and gonads, is the ... both of which may be subsequently converted ... activity, estimated at ~(less than or equal ... androstenedione levels often exceed testosterone in both ...
... Inhibins are heterodimeric proteins that suppress ... from the pituitary. Inhibin consists of two ... linked together. Inhibin A consists of the ... the alpha-subunit and betaB-subunit. Only the dimeric ...
... a 7.5 kDa peptide which is secreted primarily ... mitogenic and metabolic actions involved in cellular growth. ... to target cell receptors. IGF-II binds with high ... monomeric protein which also serves as the receptor ...
Medicine Products: